Investors
Stock information

Explore Novonesis' stock performance, ownership structure, the analysts covering Novonesis and the latest consensus.

Stock ticker - NSIS B

Sign up for share alerts

Share information

Ownership structure

Management in Novonesis is headed by the Board of Directors and the Executive Leadership Team. The leadership and governance structure promotes transparent and sustainable corporate value creation.

Novonesis’ stock consists of two types: A and B shares. Both shares have a nominal value of DKK 2 per share, but an A share carries 10 times as many votes as a B share.

Just after completion of the merger between Novozymes and Chr. Hansen, Novonesis had approximately 100.000 shareholders. At that time Novo Holdings A/S held 23.87% of the total common stock and controlled 62.55% of the votes. Novo Holdings A/S is the holding company for companies in the Novo Group.

Analyst coverage

Names and analyst details of the financial institutions covering Novonesis with equity research.

CompanyAnalystEmailPhone no.Sector(s) covered:AddressCity & ZipcodeCountry
AlphaValueVirendra Singh Chauhan v.chauhan@alphavalue.eu +91 120 4508000Multiple sectors48 Boulevard des BatignollesParis 75017France
Bank of AmericaAlexander Jones alexander.jones2@bofa.com+44 20 7995 5828Chemicals2 King Edward StLondon EC1A 1HQUnited Kingdom
BarclaysAlex Sloane alexander.sloane@barclays.com +44 (0) 203 555 0645European consumer staples1 Churchill Place, Canary WharfLondon, E14 5HPUnited Kingdom
BerenbergSebastian Bray sebastian.bray@berenberg.com+44 20 3753 3011Chemicals60 Threadneedle StreetLondon EC2R 8HPUnited Kingdom
BernsteinGünther Zechmann gunther.zechmann@bernstein.com +44 20 7170 5019Chemicals50 Berkeley StLondon W1J 8HAUnited Kingdom
BNP ParibasNicola Tang nicola.tang@uk.bnpparibas.com +44 7785 740855Global chemicals10 Harewood AvenueLondon NW1 6AAUnited Kingdom
CarnegieLars Topholm lars.topholm@carnegie.dk +45 3288 0353Multiple sectorsOvergaden Neden Vandet 9B1414 CopenhagenDenmark
CitigroupRanulf Orr ranulf.orr@citi.com +44 20 7986 3922Chemicals & basic materials33 Canada Square, Canary WharfLondon E14 5LBUnited Kingdom
Danske BankAndré Thormann thorm@danskebank.dk +45 27 79 29 44Food & beverageHolmens Kanal 2-121092 CopenhagenDenmark
Deutsche BankVirginie Boucher-Ferte virginie.boucher-ferte@db.com +33 144 955934European chemical & ingredients23-25, Avenue Franklin D. Roosevelt75008 ParisFrance
DNBRune Majlund Dahl rune.dahl@dnb.no +45 25 55 01 22Multiple sectorsArne Jacobsens Allé 152300 CopenhagenDenmark
Goldman SachsGeorgina Frasergeorgina.fraser@gs.com-European chemicalsPlumtree Court, 25 Shoe LaneLondon EC4A 4AUUnited Kingdom
HandelsbankenMattias Häggblommattias.haggblom@handelsbanken.se+46 702 04 40 78Nordic life sciencesKungsträdgårdsgatan 2SE-10670 StockholmSweden
JefferiesCharles Bentley cbentley@jefferies.com +44 20 7029 8000European chemicals100 BishopsgateLondon EC2N 4JLUnited Kingdom
J.P. MorganChetan Udeshi chetan.x.udeshi@jpmorgan.com +44 207 742 7034European chemicals25 Bank StreetLondon E14 5JPUnited Kingdom
Jyske BankMorten Holm Enggard moen@jyskebank.dk +45 8989 7154Multiple sectorsVestergade 8-168600 SilkeborgDenmark
Kepler CheuvreuxAnalyst changeover ---Johannes Vermeerstraat 91071 DK AmsterdamNetherlands
MorningstarDiana Radu diana.radu@morningstar.com +31 20 797 1557European consumer packaged goods & specialty chemicalsDe Entrée 2461101 EE AmsterdamNetherlands
NordeaThomas Lind Petersen thomas.lind.petersen@nordea.dk +45 5547 9938Multiple sectorsGroenjordsvej 102300 CopenhagenDenmark
SEBSøren Samsøe soren.samsoe@enskilda.dk +45 3328 3306Food, beverages, ingredients & retailBernstorffsgade 501577 CopenhagenDenmark
UBSCharles Eden charles.eden@ubs.com +44 (0) 20 7568 9622European consumer chemicals & ingredients5 BroadgateLondon EC2M 2QSUnited Kingdom

Consensus

You can download the consensus pre-Q1 2024 here.

Download consensus

  • Contact investor relations

    Should you have any questions about the reports and presentations, please don't hesitate to get in touch with our investor relations team.

    Get in touch

  • Investor homepage

    Are you interested in further exploring investor-related information? Check out our Investor homepage.

    Explore the Investor homepage